FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer |
Kim, Gi-Won
(Department of Radiation Oncology, The Catholic University of Korea School of Medicine)
Kim, Yeon-Sil (Department of Radiation Oncology, The Catholic University of Korea School of Medicine) Han, Eun-Ji (Department of Radiology, The Catholic University of Korea School of Medicine) Yoo, Ie-Ryung (Department of Radiology, The Catholic University of Korea School of Medicine) Song, Jin-Ho (Department of Radiation Oncology, The Catholic University of Korea School of Medicine) Lee, Sang-Nam (Department of Radiation Oncology, The Catholic University of Korea School of Medicine) Lee, Jong-Hoon (Department of Radiation Oncology, The Catholic University of Korea School of Medicine) Choi, Byung-Oak (Department of Radiation Oncology, The Catholic University of Korea School of Medicine) Jang, Hong-Seok (Department of Radiation Oncology, The Catholic University of Korea School of Medicine) Yoon, Sei-Chul (Department of Radiation Oncology, The Catholic University of Korea School of Medicine) |
1 | Ajani JA, Winter KA, Gunderson LL, et al. Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11). Cancer 2010;116:4007-13. DOI ScienceOn |
2 | Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44. DOI ScienceOn |
3 | Wong RJ, Lin DT, Schoder H, et al. Diagnostic and prognostic value of (18)F-fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-208. DOI ScienceOn |
4 | Ong SC, Schoder H, Lee NY, et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer. J Nucl Med 2008;49:532-40. DOI ScienceOn |
5 | Shintani SA, Foote RL, Lowe VJ, Brown PD, Garces YI, Kasperbauer JL. Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer. Int J Radiat Oncol Biol Phys 2008;70:322-9. DOI ScienceOn |
6 | Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-18F-fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 2004;59:1295-300. DOI ScienceOn |
7 | Minn H, Lapela M, Klemi PJ, et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 1997;38:1907-11. |
8 | Liao CT, Chang JT, Wang HM, et al. Preoperative 18F-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys 2009;74:1054-61. DOI ScienceOn |
9 | Moeller BJ, Rana V, Cannon BA, et al. Prospective risk-adjusted 18F-Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 2009;27:2509-15. DOI ScienceOn |
10 | Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo) radiotherapy in head and neck cancer. Head Neck 2005;27:175-81. DOI ScienceOn |
11 | Yao M, Smith RB, Graham MM, et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2005;63:991-9. DOI ScienceOn |
12 | Chung MK, Jeong HS, Park SG, et al. Metabolic tumor volume of 18F-fluorodeoxyglucose positron emission tomography/ computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Clin Cancer Res 2009;15:5861-8. DOI ScienceOn |
13 | Abgral R, Querellou S, Potard G, et al. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 2009;50:24-9. |
14 | Kao J, Vu HL, Genden EM, et al. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer 2009;115:4586-94. DOI ScienceOn |
15 | Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 2000;18:651-8. |
16 | Andrade RS, Heron DE, Degirmenci B, et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 2006;65:1315-22. DOI ScienceOn |
17 | La TH, Filion EJ, Turnbull BB, et al. Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;74:1335-41. DOI ScienceOn |
18 | Liao CT, Chang JT, Wang HM, et al. Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys 2009;73:764-71. DOI ScienceOn |
19 | Koike I, Ohmura M, Hata M, et al. FDG-PET scanning after radiation can predict tumor regrowth three months later. Int J Radiat Oncol Biol Phys 2003;57:1231-8. DOI ScienceOn |
20 | Yao M, Smith RB, Hoffman HT, et al. Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report. Int J Radiat Oncol Biol Phys 2009;74:9-14. DOI ScienceOn |
21 | Lee P, Weerasuriya DK, Lavori PW, et al. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys 2007;69:328-33. DOI ScienceOn |
22 | Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996;36:999-1004. DOI ScienceOn |
![]() |